Skip to Content

AG (Risedronate Sodium Delayed-Release 35 mg)

Pill with imprint AG is Orange, Elliptical / Oval and has been identified as Risedronate Sodium Delayed-Release 35 mg. It is supplied by Impax Laboratories, Inc..

Risedronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AG

Risedronate Sodium Delayed-Release

Imprint
AG
Strength
35 mg
Color
Orange
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Impax Laboratories, Inc.
National Drug Code (NDC)
00115-1426

Get help with Imprint Code FAQs.

Related Images for "AG"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.